This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With support from the Foundation for Opioid Response Efforts (FORE), publichealth law experts from Indiana University McKinney School of Law and the Temple University Center for PublicHealth Law Research at the Beasley School of Law recently embarked on a systematic review of U.S.
The federal government and several states have implemented strategies to improve and promote OUD treatment access, especially for the relatively inexpensive and effective medication buprenorphine. Dr. Hincapie-Castillo and Dr. Goodin are Research Fellows at the Center for PublicHealth Law Research.
Digital health technology has seen an incredible growth in the last few years, fueled by a combination of consumerization of wearable technologies, ubiquity of mobile devices, proliferation of technology incubators, attention by governmenthealth and regulatory agencies and involvement of large companies heretofore not focused on healthcare.
trillion omnibus appropriations bill has been released by the House and Senate Appropriations Committees which, if passed, will ensure that the government remains funded until September 30, 2023. The bill must be signed by the president on Friday this week, when government funding is set to expire. The text of a $1.7
It also requires that the Secretary report to Congress on the state of the SNS, and to issue guidance and hold annual meetings with publichealth officials and stakeholders on how states, territories, and Tribes can access the SNS. Modernizes publichealth data through biosurveillance and infectious disease data collection.
Earlier this week, the United States Department of Health and Human Services (“HHS”) released a Notice of Proposed Rulemaking (“NPRM”) that proposes to make sweeping changes to regulations at 42 C.F.R. part 2 (“Part 2”) governing the confidentiality of substance use disorder (“SUD”) records.
News In a temporary rule, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) extended telemedicine flexibilities for prescribing controlled medications for six months following the end of the publichealth emergency, through November 11.
Ultimately, accurate billing not only ensures fair compensation for services rendered but also underpins the sustained provision of life-saving MAT interventions, embodying the pivotal role of billing proficiency in advancing publichealth initiatives. Looking to streamline your billing process?
As a result, if a patient and a practitioner have appropriately established a telemedicine relationship on or before November 11, 2023, the same telemedicine flexibilities that have governed the relationship to that point will continue to be permitted until November 11, 2024.
"We serve the same families in our Administration for Children and Families that we serve with Medicare and Medicaid, that we serve in our Substance Abuse and Mental HealthServicesAdministration," said Palm. "We're all the same people who need CDC when we need them, etc.
In the proposed rules regarding buprenorphine DEA says that a practitioner must be registered in the state where he/she is located, however, DEA does not address this issue in its proposed rules governing the special registration requirements generally. 21 U.S.C. § 802(17).
trillion spending package, which consists of all 12 fiscal year (FY) 2023 appropriations bills and funds the federal government through September 30, 2023, provides additional assistance to Ukraine, and makes numerous health care policy changes. million Centers for Medicare & Medicaid Services (CMS) $4.1
In November 2022, OCR and the Substance Abuse and Mental HealthServicesAdministration (SAMHSA) issued a Notice of Proposed Rulemaking (NPRM) which sees both Part 2 and HIPAA changes to better align these regulations. Proposed Part 2 and HIPAA Changes in 2023.
Department of Health and Human Services (HHS) has announced a significant restructuring initiative, undertaken in accordance with President Trump’s Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.”
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content